Latest Period
Q4 2025
Security Snapshot
Guardant Health, Inc. - Common Stock (GH) Institutional Ownership
CUSIP: 40131M109
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
492
Shares (Excl. Options)
131,054,929
Price
$102.14
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- GH on Nasdaq
- Shares outstanding
- 131,262,829
- Price per share
- $87.17
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 131,054,929
- Total reported value
- $13,384,661,636
- % of total 13F portfolios
- 0.01%
- Share change
- +7,570,264
- Value change
- +$814,528,239
- Number of holders
- 492
- Price from insider filings
- $87.17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- GH - Guardant Health, Inc. - Common Stock is tracked under CUSIP 40131M109.
- 492 institutions reported positions in Q4 2025.
- 5 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 492 to 266 between Q4 2025 and Q1 2026.
- Reported value moved from $13,384,661,636 to $3,966,809,675.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 492 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 40131M109:
Significant Owners of Guardant Health, Inc. - Common Stock (GH) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.5% | $460,074,314 | 9,288,801 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $608,662,324 | 6,589,394 | Vanguard Capital Management | 31 Mar 2026 | |||
| Deep Track Capital, LP | 4.4% | $269,627,501 | 5,443,721 | Deep Track Capital, LP | 31 Mar 2025 | |||
| CADIAN CAPITAL MANAGEMENT, LP | 4.2% | $258,624,114 | 5,221,565 | Cadian Capital Management, LP | 31 Dec 2024 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 3.9% | $240,233,923 | 4,850,271 | Wellington Management Group LLP | 31 Dec 2024 |
As of 31 Dec 2025, 492 institutional investors reported holding 131,054,929 shares of Guardant Health, Inc. - Common Stock (GH). This represents 100% of the company’s total 131,262,829 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Guardant Health, Inc. - Common Stock (GH) together control 65% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 9.3% | 12,160,768 | +2.1% | 0.02% | $1,242,100,844 |
| BlackRock, Inc. | 8.6% | 11,317,714 | -0.98% | 0.02% | $1,155,991,262 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.3% | 5,636,078 | +34% | 0.06% | $575,670,000 |
| Invesco Ltd. | 4% | 5,315,934 | +7.8% | 0.08% | $542,969,482 |
| BAILLIE GIFFORD & CO | 3.7% | 4,890,026 | -4.6% | 0.42% | $499,467,256 |
| Capital International Investors | 2.7% | 3,528,656 | -25% | 0.06% | $360,416,924 |
| FRANKLIN RESOURCES INC | 2.6% | 3,361,547 | +15% | 0.08% | $343,348,455 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 3,213,657 | +9.4% | 0.02% | $328,296,726 |
| Deep Track Capital, LP | 2.1% | 2,800,000 | -33% | 6.5% | $285,992,000 |
| STATE STREET CORP | 2.1% | 2,795,727 | +0.29% | 0.01% | $285,555,556 |
| GOLDMAN SACHS GROUP INC | 2% | 2,627,709 | +74% | 0.04% | $268,394,156 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.9% | 2,511,091 | -24% | 4% | $256,454,805 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.9% | 2,441,730 | +3% | 0.84% | $249,398,349 |
| FMR LLC | 1.8% | 2,396,433 | +191% | 0.01% | $244,771,750 |
| TWO SIGMA ADVISERS, LP | 1.8% | 2,382,300 | +13% | 0.47% | $243,328,122 |
| TWO SIGMA INVESTMENTS, LP | 1.7% | 2,171,903 | +20% | 0.33% | $221,838,172 |
| Driehaus Capital Management LLC | 1.6% | 2,143,193 | -0.42% | 1.5% | $218,905,733 |
| FEDERATED HERMES, INC. | 1.5% | 2,031,562 | +14% | 0.35% | $207,503,743 |
| LORD, ABBETT & CO. LLC | 1.5% | 1,988,983 | +31% | 0.62% | $203,155,000 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.5% | 1,915,581 | -15% | 0.04% | $195,657,444 |
| ALLIANCEBERNSTEIN L.P. | 1.4% | 1,901,308 | +1263% | 0.06% | $194,199,599 |
| UBS Group AG | 1.3% | 1,710,169 | +17% | 0.03% | $174,676,662 |
| Point72 Asset Management, L.P. | 1.1% | 1,499,169 | +1364% | 0.24% | $153,125,122 |
| RTW INVESTMENTS, LP | 1.1% | 1,481,033 | 0% | 1.5% | $151,272,711 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1% | 1,457,676 | +3% | 0.02% | $148,887,039 |
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 43,030,940 | $3,966,809,675 | -$387,334,063 | $92.37 | 266 |
| 2025 Q4 | 131,054,929 | $13,384,661,636 | +$814,528,239 | $102.14 | 492 |
| 2025 Q3 | 122,493,323 | $7,653,044,062 | -$62,866,800 | $62.48 | 388 |
| 2025 Q2 | 124,295,969 | $6,467,826,507 | +$330,760,770 | $52.04 | 359 |
| 2025 Q1 | 118,497,703 | $5,048,168,027 | +$16,046,986 | $42.60 | 336 |
| 2024 Q4 | 119,495,658 | $3,649,677,643 | -$152,886,448 | $30.55 | 294 |
| 2024 Q3 | 124,539,664 | $2,855,453,478 | +$192,800,636 | $22.94 | 264 |
| 2024 Q2 | 114,848,348 | $3,316,872,682 | +$179,592,491 | $28.88 | 274 |
| 2024 Q1 | 111,383,571 | $2,296,334,142 | -$29,707,645 | $20.63 | 252 |
| 2023 Q4 | 110,309,454 | $2,983,894,470 | +$45,961,733 | $27.05 | 289 |
| 2023 Q3 | 108,297,993 | $3,210,080,906 | -$83,646,730 | $29.64 | 289 |
| 2023 Q2 | 110,144,879 | $3,943,258,288 | +$694,610,966 | $35.80 | 293 |
| 2023 Q1 | 92,579,337 | $2,168,850,990 | -$17,004,713 | $23.44 | 271 |
| 2022 Q4 | 94,289,245 | $2,564,763,814 | -$199,503,944 | $27.20 | 280 |
| 2022 Q3 | 94,962,606 | $5,108,852,818 | +$162,272,236 | $53.83 | 310 |
| 2022 Q2 | 92,768,225 | $3,745,003,930 | -$39,996,274 | $40.34 | 310 |
| 2022 Q1 | 92,443,619 | $6,110,748,734 | -$81,915,249 | $66.24 | 335 |
| 2021 Q4 | 92,085,897 | $9,209,883,362 | -$251,467,115 | $100.02 | 379 |
| 2021 Q3 | 94,130,065 | $11,765,302,482 | +$583,304,963 | $125.01 | 365 |
| 2021 Q2 | 89,577,134 | $11,124,047,648 | -$275,498,694 | $124.19 | 410 |
| 2021 Q1 | 91,351,911 | $13,941,648,366 | +$681,296,473 | $152.65 | 410 |
| 2020 Q4 | 87,374,557 | $11,260,127,731 | +$219,249,861 | $128.88 | 399 |
| 2020 Q3 | 85,443,260 | $9,550,543,816 | +$176,117,596 | $111.78 | 341 |
| 2020 Q2 | 84,323,375 | $6,840,933,865 | +$491,051,528 | $81.13 | 311 |
| 2020 Q1 | 78,329,707 | $5,451,350,483 | +$31,071,063 | $69.60 | 281 |
| 2019 Q4 | 77,055,101 | $6,021,065,515 | +$259,064,552 | $78.14 | 261 |
| 2019 Q3 | 73,811,798 | $4,711,407,821 | -$154,907,012 | $63.83 | 230 |
| 2019 Q2 | 75,988,996 | $6,559,989,770 | +$1,412,721,312 | $86.33 | 214 |
| 2019 Q1 | 60,292,447 | $4,622,332,723 | +$11,801,888 | $76.70 | 144 |
| 2018 Q4 | 61,703,860 | $2,318,551,779 | +$2,050,102,770 | $37.59 | 87 |